Midatech Pharma PLC | Income Statement
Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
147.00
25.00
775.00
6,376.00
6,758.00
149
Cost of Goods Sold (COGS) incl. D&A
247.00
-
807.00
5,022.00
3,486.00
-
Gross Income
100.00
-
32.00
1,354.00
3,272.00
-
SG&A Expense
4,399.00
8,498.00
10,660.00
19,974.00
20,202.00
12,265
EBIT
4,499.00
-
10,692.00
18,073.00
16,930.00
13,227
Unusual Expense
-
935.00
1,353.00
11,340.00
1,500.00
-
Non Operating Income/Expense
-
43.00
765.00
-
1,252.00
1,412
Interest Expense
385.00
161.00
5.00
73.00
166.00
587
Pretax Income
4,883.00
9,840.00
11,232.00
29,322.00
17,329.00
12,400
Income Tax
799.00
1,018.00
1,133.00
9,160.00
1,265.00
2,032
Consolidated Net Income
4,084.00
8,822.00
10,099.00
20,162.00
16,064.00
10,368
Net Income
4,084.00
8,822.00
10,099.00
20,162.00
16,064.00
10,368
Net Income After Extraordinaries
4,084.00
8,822.00
10,099.00
20,162.00
16,064.00
5,706
Net Income Available to Common
4,084.00
8,822.00
10,099.00
20,162.00
16,064.00
13,623
EPS (Basic)
0.15
0.97
0.36
0.56
0.31
0.24
Basic Shares Outstanding
28,006.50
9,095.30
28,445.30
36,153.80
51,317.30
62,038.80
EPS (Diluted)
0.15
0.97
0.36
0.56
0.31
0.24
Diluted Shares Outstanding
28,006.50
9,095.30
28,445.30
36,153.80
51,317.30
62,038.80
EBITDA
4,252.00
8,473.00
9,955.00
13,718.00
14,370.00
12,116
Other Operating Expense
-
-
-
547.00
-
-
Non-Operating Interest Income
1.00
8.00
53.00
164.00
15.00
2
About Midatech Pharma
View Profile
